Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- shortness of breath and fatigue
- lymphadenopathy
- splenomegaly
- hepatomegaly
Другие диагностические факторы
- B symptoms
- recurrent infections
- epistaxis
- pallor
- petechiae
Диагностические исследования
Исследования, которые показаны в первую очередь
- CBC count with differential
- flow cytometry
- peripheral blood smear
Исследования, проведение которых нужно рассмотреть
- serum beta-2 microglobulin
- fluorescent in situ hybridization (FISH)
- molecular genetic tests
- direct antiglobulin test (DAT)
- serum quantitative immunoglobulin
- CT scan/fluorodeoxyglucose (FDG)-PET/CT
Алгоритм лечения
Составители
Авторы
Jacqueline C. Barrientos, MD, MS
Associate Professor
Department of Medicine
Zucker School of Medicine at Hofstra/Northwell
CLL Research & Treatment Program
Northwell Health Cancer Institute
Lake Success, NY
Раскрытие информации
JCB has been a consultant for Beigene, Abbvie, and AstraZeneca; received honoraria from Janssen; and received research funding from Oncternal, VelosBio, and Pharmacyclics.
Joanna M. Rhodes, MD, MSCE
Assistant Professor
Department of Medicine
Zucker School of Medicine at Hofstra/Northwell
CLL Research and Treatment Program
Northwell Health Cancer Institute
Lake Success, NY
Раскрытие информации
JMR has received consulting fees from AbbVie, ADC Therapeutics, AstraZeneca, BeOne, BMS, Epizyme, Genentech, GenMab, Janssen, Johnson & Johnson, MorphoSys, Pharmacyclics, Seagen, TG Therapeutics, Verastem, Pfizer, and Incyte. JMR’s institution has received research support from AbbVie, Acerta, ADC Therapeutics, AstraZeneca, Acrotech, BeOne, Janssen, Johnson & Johnson, Loxo Oncology, Oncternal Therapeutics, Pharmacyclics, VelosBio, and Merck.
Выражение благодарностей
Dr Jacqueline C. Barrientos and Dr Joanna M. Rhodes would like to gratefully acknowledge Dr Vidhya Murthy, Dr Shankaranarayana Paneesha, and Dr Robert Chen, previous contributors to this topic.
Раскрытие информации
VM has received a consultancy fee from Janssen, and a grant from Takeda for the ASH Annual Meeting 2014. SP has received consultancy and speaker fees from Janssen, Gilead, AbbVie, Bristol-Myers Squibb, and Takeda. RC declares that he has no competing interests.
Рецензенты
Alessandra Ferrajoli, MD
Associate Medical Director, Professor
Department of Leukemia Center
The University of Texas MD Anderson Cancer Center
Houston, TX
Раскрытие информации
AF declares that she has no competing interests.
Farrukh Awan, MD
Professor of Medicine
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX
Раскрытие информации
FA declares that he has no competing interests.
Paolo F. Caimi, MD
Associate Professor
Department of Medicine
Case Western Reserve University
Case Comprehensive Cancer Center
Cleveland, OH
Раскрытие информации
PFC has received honoraria from Celgene for participation in a speaker bureau, and from Kite Pharma for participation in an advisory board.
Daniel Catovsky, MD, FRCP, FRCPath, DSc, FMedSc
Consultant Haemato-oncologist
Section of Haemato-Oncology
The Institute of Cancer Research
Sutton
UK
Раскрытие информации
Unfortunately, we have since been made aware that DC is deceased
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 Jun 21;131(25):2745-60.Полный текст Аннотация
Walewska R, Parry-Jones N, Eyre TA, et al. Guideline for the treatment of chronic lymphocytic leukaemia. Br J Haematol. 2022 Jun;197(5):544-57.Полный текст Аннотация
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma [internet publication].Полный текст
Eichhorst B, Robak T, Montserrat E, et al; ESMO Guidelines Committee. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Jan;32(1):23-33.Полный текст Аннотация
Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021 Dec 1;96(12):1679-705.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available here.
Использование этого контента попадает под действие нашего заявления об отказе от ответственности